Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,935 | 364 | 97.5% |
| Education | $177.25 | 7 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,024 | 63 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $775.92 | 46 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $647.13 | 31 | $0 (2024) |
| Genentech USA, Inc. | $608.59 | 27 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $542.16 | 22 | $0 (2024) |
| Insmed, Inc. | $404.08 | 16 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $400.13 | 30 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $238.62 | 15 | $0 (2023) |
| Grifols USA, LLC | $225.59 | 17 | $0 (2022) |
| GENZYME CORPORATION | $222.90 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $933.07 | 33 | GlaxoSmithKline, LLC. ($177.89) |
| 2023 | $927.35 | 46 | GlaxoSmithKline, LLC. ($191.21) |
| 2022 | $578.32 | 29 | GlaxoSmithKline, LLC. ($277.66) |
| 2021 | $398.18 | 21 | Actelion Pharmaceuticals US, Inc. ($238.96) |
| 2020 | $581.80 | 26 | Insmed, Inc. ($247.53) |
| 2019 | $1,208 | 62 | Genentech USA, Inc. ($272.27) |
| 2018 | $1,261 | 71 | Genentech USA, Inc. ($221.80) |
| 2017 | $1,224 | 83 | Sunovion Pharmaceuticals Inc. ($214.28) |
All Payment Transactions
371 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $31.91 | General |
| Category: Narcoplepsy | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $112.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $39.63 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $37.15 | General |
| Category: Narcoplepsy | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $120.72 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,787 | 2,196 | $428,905 | $161,204 |
| 2022 | 26 | 1,762 | 2,301 | $467,065 | $170,375 |
| 2021 | 26 | 1,921 | 2,641 | $560,431 | $206,371 |
| 2020 | 25 | 1,875 | 2,700 | $605,168 | $226,517 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 319 | 408 | $81,600 | $35,881 | 44.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 138 | 297 | $56,430 | $26,519 | 47.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 161 | 164 | $57,400 | $21,195 | 36.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 173 | 265 | $34,450 | $15,809 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 259 | $34,965 | $15,350 | 43.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 50 | 75 | $30,375 | $11,966 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $19,520 | $7,457 | 38.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,244 | $5,139 | 98.0% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 138 | 145 | $14,500 | $3,643 | 25.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 26 | 29 | $17,400 | $2,636 | 15.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 58 | 62 | $8,680 | $2,404 | 27.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $5,760 | $2,090 | 36.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 22 | 22 | $13,200 | $1,967 | 14.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,800 | $1,829 | 38.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 14 | 14 | $6,300 | $1,476 | 23.4% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 15 | 15 | $7,500 | $806.59 | 10.8% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 12 | $5,400 | $718.87 | 13.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 23 | 23 | $3,335 | $624.91 | 18.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $630.00 | $589.05 | 93.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 23 | $2,645 | $502.95 | 19.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 16 | 16 | $1,840 | $492.16 | 26.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $480.00 | $448.80 | 93.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 49 | 49 | $6,987 | $363.21 | 5.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 40 | 40 | $3,058 | $343.40 | 11.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 49 | 49 | $5,001 | $313.54 | 6.3% |
About Dr. Todd Henderson, MD
Dr. Todd Henderson, MD is a Critical Care Medicine healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710163050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Henderson, MD has received a total of $7,112 in payments from pharmaceutical and medical device companies, with $933.07 received in 2024. These payments were reported across 371 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,935).
As a Medicare-enrolled provider, Henderson has provided services to 7,345 Medicare beneficiaries, totaling 9,838 services with total Medicare billing of $764,468. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Southaven, MS
- Active Since 01/16/2008
- Last Updated 03/28/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1710163050
Products in Payments
- TRELEGY ELLIPTA (Drug) $492.12
- UPTRAVI (Drug) $400.67
- Arikayce (Drug) $366.16
- NUCALA (Biological) $364.37
- OFEV (Drug) $289.56
- Xolair (Biological) $277.28
- Adempas (Drug) $238.62
- UTIBRON (Drug) $195.18
- WAKIX (Drug) $194.88
- OPSUMIT MACITENTAN (Drug) $184.75
- FASENRA (Drug) $172.53
- Utibron (Drug) $162.01
- BREZTRI (Drug) $152.87
- OPSUMIT (Drug) $147.07
- DUPIXENT (Drug) $142.63
- remede System (Device) $140.80
- DUPIXENT (Biological) $132.20
- TEZSPIRE (Biological) $127.73
- WINREVAIR (Biological) $122.69
- Prolastin-C Liquid (Biological) $121.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Southaven
Istvan Wollak, M.d, M.D
Critical Care Medicine — Payments: $5,668
Dr. Yadana Kyaw, Md, MD
Critical Care Medicine — Payments: $4,662
Sanjay Ratnakant, M.d, M.D
Critical Care Medicine — Payments: $3,688
John Walker, Crna, CRNA
Critical Care Medicine